127 related articles for article (PubMed ID: 38159645)
21. Hepatic infantile hemangiomas treated with oral propranolol--a case series.
Mhanna A; Franklin WH; Mancini AJ
Pediatr Dermatol; 2011; 28(1):39-45. PubMed ID: 21261702
[TBL] [Abstract][Full Text] [Related]
22. Patient Perspectives: Propranolol for infantile hemangiomas.
Pediatr Dermatol; 2016 Sep; 33(5):549-50. PubMed ID: 27595871
[No Abstract] [Full Text] [Related]
23. Experience with Holter monitoring during propranolol therapy for infantile hemangiomas.
Jacks SK; Kertesz NJ; Witman PM; Fernandez Faith E
J Am Acad Dermatol; 2015 Aug; 73(2):255-7. PubMed ID: 26054433
[TBL] [Abstract][Full Text] [Related]
24. Propranolol for infantile hemangiomas with hyperinsulinemic hypoglycemia.
Miyazaki T; Ozeki M; Sasai H; Ohnishi H
Pediatr Int; 2021 Jun; 63(6):724-725. PubMed ID: 34042227
[No Abstract] [Full Text] [Related]
25. Excessively High Chronic Propranolol Overdose in Infantile Hemangioma: A Case Report.
Alshammari H; Alessa A; Elsharawy Y; Alghanem A; Alhammad AM
Am J Case Rep; 2023 Nov; 24():e941765. PubMed ID: 38008932
[TBL] [Abstract][Full Text] [Related]
26. Delayed-onset of multiple cutaneous infantile hemangiomas due to propranolol: a case report.
Porcel Chacón R; del Boz González J; Navarro Morón J
Pediatrics; 2015 Apr; 135(4):e1064-6. PubMed ID: 25780066
[TBL] [Abstract][Full Text] [Related]
27. Infantile hemangiomas: what have we learned from propranolol?
Hagen R; Ghareeb E; Jalali O; Zinn Z
Curr Opin Pediatr; 2018 Aug; 30(4):499-504. PubMed ID: 29846253
[TBL] [Abstract][Full Text] [Related]
28. Recurrence of infantile hemangiomas treated with propranolol.
Bagazgoitia L; Hernández-Martín Á; Torrelo A
Pediatr Dermatol; 2011; 28(6):658-662. PubMed ID: 22082463
[TBL] [Abstract][Full Text] [Related]
29. Preliminary experiences in treating infantile hemangioma with propranolol.
Chai Q; Chen WL; Huang ZQ; Zhang DM; Fan S; Wang L
Ann Plast Surg; 2014 Feb; 72(2):169-72. PubMed ID: 21629056
[TBL] [Abstract][Full Text] [Related]
30. Color Doppler Ultrasound Indices as Predictors of Propranolol Response in Infantile Hemangioma: A Prospective Study.
Pandey V; Bera RN; Diwedi AND; Singh OP; Tiwari P
Indian Pediatr; 2024 Mar; 61(3):237-242. PubMed ID: 38469839
[TBL] [Abstract][Full Text] [Related]
31. Oral propranolol for infantile hemangiomas beyond the proliferative phase.
Kagami S; Katori T
J Dermatol; 2018 Oct; 45(10):1199-1202. PubMed ID: 30051930
[TBL] [Abstract][Full Text] [Related]
32. Hemangiomas of the nasal tip treated with propranolol.
Ben-Amitai D; Halachmi S; Zvulunov A; Raveh E; Kalish E; Lapidoth M
Dermatology; 2012; 225(4):371-5. PubMed ID: 23428617
[TBL] [Abstract][Full Text] [Related]
33. Propranolol for the treatment of ulcerated infantile hemangiomas: A prospective study.
Ji Y; Yang K; Zhou J; Zhang X; Xiang B; Jiang X; Xu X; Qiu T; Dai S; Kong F; Lu G; Qiu Q; Zhang Y; Chen S
J Am Acad Dermatol; 2022 May; 86(5):1149-1151. PubMed ID: 33895205
[No Abstract] [Full Text] [Related]
34. Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants.
Erbay A; Sarialioglu F; Malbora B; Yildirim SV; Varan B; Tarcan A; Gülcan H; Demir S; Derbent M; Uslu N; Abbasoğlu A
Turk J Pediatr; 2010; 52(5):450-6. PubMed ID: 21434528
[TBL] [Abstract][Full Text] [Related]
35. Beta Blockade as Treatment for Intracranial Infantile Hemangioma: Case Report and Literature Review.
Kang E; Friedman N; Mamoun I; Tamburro J; Golden A
Pediatr Neurol; 2016 Jun; 59():13-7. PubMed ID: 27068061
[TBL] [Abstract][Full Text] [Related]
36. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
[TBL] [Abstract][Full Text] [Related]
37. Propranolol for the treatment of orbital infantile hemangiomas.
Fridman G; Grieser E; Hill R; Khuddus N; Bersani T; Slonim C
Ophthalmic Plast Reconstr Surg; 2011; 27(3):190-4. PubMed ID: 21283032
[TBL] [Abstract][Full Text] [Related]
38. Successful discontinuation of propranolol for infantile hemangiomas of the head and neck at 12 months of age.
Hong P; Tammareddi N; Walvekar R; Chiu ES; Poole JC; Kluka EA; Simon LM
Int J Pediatr Otorhinolaryngol; 2013 Jul; 77(7):1194-7. PubMed ID: 23706952
[TBL] [Abstract][Full Text] [Related]
39. Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report.
Breur JM; de Graaf M; Breugem CC; Pasmans SG
Pediatr Dermatol; 2011; 28(2):169-71. PubMed ID: 20738795
[TBL] [Abstract][Full Text] [Related]
40. Nadolol for Infantile Hemangiomas Previously Treated with Propranolol.
Colmenero Sendra M; Del Boz González J; Segura Palacios JM; Valladares Millán I; Eguiluz Solana M; de Troya Martín M
Actas Dermosifiliogr; 2024 Feb; 115(2):215-217. PubMed ID: 37356545
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
